Mister Spex (MRX) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Q3 2024 marked a transition period with restructuring, layoffs, store closures, and a shift from top-line growth to long-term cash generation and profitability, supported by the SpexFocus transformation program.
Net revenue for Q3 was €58 million, down 3% year-over-year, with Germany up 2% and International down 17% due to store closures and restructuring.
Gross margin improved by 302 basis points to 48.8% in Q3, driven by price increases, reduced discounts, and the launch of premium products.
Adjusted EBITDA for Q3 was -€1.2 million, reflecting lower sales, higher operating expenses, and one-time restructuring costs.
Financial highlights
Net revenues for Q3 were €58 million, a 3% year-over-year decline; gross profit margin rose to 48.8% from 45.8% year-over-year.
Adjusted EBITDA margin was -2.5% in Q3, down from 0.4% in Q3 2023.
Net loss for Q3 2024 was €15.3 million, compared to €8.7 million in Q3 2023; EPS at -€0.47.
Cash and cash equivalents stood at €81.6 million at the end of September 2024, with a year-end target of €70 million.
Operating cash flow declined by €6 million, mainly due to lower revenues and restructuring costs.
Outlook and guidance
2024 guidance confirmed: net revenue €210–230 million, adjusted EBITDA margin between -4% and +1%, and year-end cash ~€70 million.
Most of the €20 million EBITDA uplift from SpexFocus expected to materialize in 2025.
Remaining international stores to close by year-end, with final one-off charges and asset impairments expected.
No new store openings planned for 2024; focus remains on higher-margin categories and increasing average order value.
Latest events from Mister Spex
- Margin expansion and structural improvements drove a €59m EBIT improvement and profitability inflection.MRX
Q4 202526 Mar 2026 - Restructuring led to a 3% revenue drop and wider losses in 2024; EBIT to improve in 2025.MRX
H2 202426 Dec 2025 - Gross margin rose to 56.4% and EBIT loss narrowed, despite a 13% revenue drop.MRX
Q1 202523 Dec 2025 - Gross margin rose to 55.0% as cost discipline offset revenue declines and losses narrowed.MRX
Q2 202523 Nov 2025 - Q3 2025 revenue fell 18%, but gross margin and EBIT improved sharply amid ongoing transformation.MRX
Q3 202513 Nov 2025 - Profitability challenges prompt transformation and rebranding amid modest revenue growth.MRX
H1 202413 Jun 2025